Over the past two decades, peptide drug discovery has experienced a remarkable renaissance, with organic chemistry and biotechnology emerging as pivotal tools for developing peptidomimetics that ...

Ultra-rapid insulins are used to manage type 1 and type 2 diabetes. Learn about the different types, their effectiveness, and how they can provide mealtime flexibility.

In a Psychopharmacologic Drugs Advisory Committee, Otsuka Pharmaceutical Co. Ltd. and the U.S. FDA spent the morning discussing three clinical trials conducted as part of the supplemental NDA for ...

The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable biosimilar product referencing Novo Nordisk A/S’ Novolog (insulin aspart), a ...

Biocon Biologics, a subsidiary of biopharmaceutical company Biocon, said on Wednesday that the US Food and Drug Administration (FDA) has approved Kirsty (Insulin Aspart), the “first and only” ...

Biocon share price today rose 3% after Biocon Biologics received US FDA approval for diabetes drug Kirsty, the first interchangeable biosimilar to NovoLog in the US. Get latest updates on Biocon ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon announced that US FDA has approved Kirsty (insulin aspart-xjhz), 100 units/mL as the first and only ...

Stocks to watch, 16 July: Stocks like HDFC Life Insurance Company, HDB Financial Services, ICICI Lombard General Insurance Company, Just Dial, Dixon Technologies, Zydus Lifesciences, Biocon ...